Publicacions en què col·labora amb Matías Antonio Llabrés Martínez (18)

2017

  1. Development of a standard method for in vitro evaluation of Triamcinolone and BMP-2 diffusion mechanism from thermosensitive and biocompatible composite hyaluronic acid-pluronic hydrogels

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 284-291

  2. Structure-Performance Relationships of Temperature-Responsive PLGA-PEG-PLGA Gels for Sustained Release of Bone Morphogenetic Protein-2

    Journal of Pharmaceutical Sciences, Vol. 106, Núm. 11, pp. 3353-3362

2016

  1. Development of an ultra high performance liquid chromatography method for determining triamcinolone acetonide in hydrogels using the design of experiments/design space strategy in combination with process capability index

    Journal of Separation Science, Vol. 39, Núm. 14, pp. 2689-2701

2014

  1. Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration

    International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 32-38

2010

  1. Anti-tumor effects of adenovirus containing human growth hormone sequences in a mouse model of human ovarian cancer

    Endocrine, Vol. 37, Núm. 3, pp. 430-439

  2. Comparison between DSC and TMDSC in the investigation into frozen aqueous cryoprotectants solutions

    Drug Development and Industrial Pharmacy, Vol. 36, Núm. 12, pp. 1413-1421

  3. Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer

    International Journal of Pharmaceutics, Vol. 388, Núm. 1-2, pp. 175-180

  4. Quality control and physical and chemical stability of hydrocortisone oral suspension: An interlaboratory study

    International Journal of Pharmaceutical Compounding, Vol. 14, Núm. 5, pp. 430-435

2009

  1. hGH release from directly compressed hGH-PLGA biodegradable implantable tablets: Influence of physicomechanical factors

    European Polymer Journal, Vol. 45, Núm. 10, pp. 2830-2838

2007

  1. A linear mixed-effects statistical model for in-vivo evaluation of recombinant human growth hormone implants in hypophysectomized rats

    Journal of Pharmacy and Pharmacology, Vol. 59, Núm. 9, pp. 1313-1317

2006

  1. A mathematical model for interpreting in vitro rhGH release from laminar implants

    International Journal of Pharmaceutics, Vol. 309, Núm. 1-2, pp. 38-43

2005

  1. Structural properties of biodegradable polyesters and rheological behaviour of their dispersions and films

    Journal of Biomaterials Science, Polymer Edition, Vol. 16, Núm. 5, pp. 629-641

2004

  1. Rheological properties of PLGA film-based implants: Correlation with polymer degradation and SPf66 antimalaric synthetic peptide release

    Biomaterials, Vol. 25, Núm. 5, pp. 925-931

  2. Stability indicating method for SPf66 antimalarial peptide in solution

    Drug Development and Industrial Pharmacy, Vol. 30, Núm. 4, pp. 389-395

2003

  1. Effect of high shear rate on stability of proteins: Kinetic study

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 33, Núm. 2, pp. 145-155

2002

  1. Chromatographic characterization of synthetic peptides: SPf66 malaria vaccine

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 766, Núm. 1, pp. 3-12

  2. Potential applications of PLGA film-implants in modulating in vitro drugs release

    International Journal of Pharmaceutics, Vol. 248, Núm. 1-2, pp. 149-156

1999

  1. Stability study of human serum albumin pharmaceutical preparations

    Journal of Pharmacy and Pharmacology, Vol. 51, Núm. 4, pp. 385-392